LaraƱo, Baby Girl M.
HRN: 21-35-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/19/2022
05/26/2022
IVT
17 Mg
24 Hrs
PROM X 17 Hrs
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes